From depression to bone health: examining the skeletal effects of classical and rapid-acting antidepressants
Abstract
Depression is a brain disorder with systemic consequences including effects on bone health. Clinical and preclinical evidence has associated major depressive disorder (MDD) with reduced bone mineral density (BMD), increased bone resorption, and higher fracture risk, particularly in older adults and postmenopausal women. Plausible mediators include chronic stress, hypothalamic-pituitary-adrenal axis dysregulation, pro-inflammatory cytokines, and altered serotonergic signaling, each of which can affect bone remodeling. Classical antidepressants, particularly selective serotonin reuptake inhibitors, have been associated with adverse skeletal outcomes in human studies, while in vitro evidence indicates effects on osteoblast differentiation, mineralization, and osteoclast activity. Human biomarker studies and preclinical evidence suggest that ketamine-related compounds can modulate bone-related pathways, although these effects appear context-, dose-, exposure-, and model-dependent. Acute and repeated ketamine administration in patients with depression has been associated with changes in bone-turnover markers, including osteoprotegerin (OPG)/receptor activator of nuclear factor kappa-B ligand (RANKL)-related, while rodent studies suggest that arketamine may attenuate stress- and ovariectomy-induced reductions in BMD and normalize the OPG/RANKL ratio. Conversely, preclinical bone-regeneration and explant data indicate that ketamine can reduce bone-cell viability and impair bone…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.